Chemical structureResearch use only

CAT. NO. DC10830Featured

IDH-889

Name: IDH-889
Brand: DC Chemicals
SKU: DC10830
Price: 400.0 USD

Pack Sizes & Prices

TotalUS$400

We match the best price and quality on market.

Product overview

Description & Application

IDH889 is an orally available, brain penetrant, allosteric and mutant specific inhibitor of isocitrate dehydrogenase 1 (IDH1). IDH889 has potent selectivity for IDH1 R132* mutations, with IC50s of 0.02 μM, 0.072 μM and 1.38 μM for IDH1R132H, IDH1R132C and IDH1wt, respectively. IDH889 shows potent cellular inhibition of R-2-hydroxyglutarate (2-HG) production with an IC50 of 0.014 μM[1].

Parameter	Value
Chemical Name	(4S)-3-[2-[[(1S)-1-[5-(4-Fluoro-3-methylphenyl)pyrimidin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
CAS No.	1429179-07-6
Synonyms	(4s)-3-[2-({(1s)-1-[5-(4-Fluoro-3-Methylphenyl)pyrimidin-2-Yl]ethyl}amino)pyrimidin-4-Yl]-4-(Propan-2-Yl)-1,3-Oxazolidin-2-One;7J2;(4S)-3-[2-[[(1S)-1-[5-(4-Fluoro-3-methylphenyl)pyrimidin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one;IDH889
Formula	C23H25FN6O2
M.Wt	436.4820
SMILES	FC1C([H])=C([H])C(=C([H])C=1C([H])([H])[H])C1C([H])=NC([C@]([H])(C([H])([H])[H])N([H])C2=NC([H])=C([H])C(=N2)N2C(=O)OC([H])([H])[C@]2([H])C([H])(C([H])([H])[H])C([H])([H])[H])=NC=1[H]
Purity	>98%
Storage	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

Target

IC50: 0.02 μM (IDH1R132H), 0.072 μM (IDH1R132C), 1.38 μM (IDH1wt)[1]

References & source

[1]. Levell JR, et al. Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1. ACS Med Chem Lett. 2016 Dec 16;8(2):151-156.

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheet Request COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

DC7174

AGI-6780

AGI-6780 that potently and selectively inhibits the tumor-associated mutant IDH2R140Q with IC50 of 23±1.7 nM. AGI-6780 is less potent against IDH2WT with IC50 of 190±8.1 nM.

View activity & prices

DC8374

Enasidenib ( AG-221)

Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.

View activity & prices

DC10439

Vorasidenib (AG881)

Vorasidenib is a pan isocitrate dehydrogenase (IDH) inhibitor.

View activity & prices

DC8051

AG-120 (Ivosidenib)

Ivosidenib (AG-120) is a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor with an IC50 of 12 nM for mouse IDH1R132H.

View activity & prices

DC11886

Adavivint

Adavivint is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells.

View activity & prices

DC5090

WZ4002

WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.

View activity & prices

DC7146

GW788388

GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, and also inhibits TGF-β type II receptor and activin type II receptor activities, without inhibiting BMP type II receptor.

View activity & prices